Tulane University

Tulane researchers studying rise in intimate partner violence amid COVID-19 pandemic

10-Aug-2020 2:35 PM EDT, by Tulane University

Newswise — The hidden and often unspoken impact of the COVID-19 pandemic has been the prevalence of intimate partner violence, according to Tulane University researchers, who are conducting a survey to determine how serious the problem is in the New Orleans area.

In a paper published by Psychological Trauma: Theory, Research, Practice and Policy, a journal of the American Psychological Association, Tulane School of Social Work professors Reggie Ferreira and Fred Buttell, say many of the strategies that are critical to ensuring public health, such as lockdowns, stay-at-home orders, social isolation and social distancing, are having a profound impact on families experiencing intimate partner violence, also known as IPV.

“In many instances of IPV, women are afraid to be alone with their abusive partners and experience a high degree of social isolation because they are afraid to tell their families and friends what is happening, out of both shame and fear that their abusive partner will hurt them, their children, or family members in retaliation for disclosure,” the researchers write.

“In effect, the public health measures to protect people from COVID-19 are increasing the amount of time that women have to spend with their abusive partners at home, which raises their risk of injury exponentially,” they say.

Ferreira is an associate professor of social work and director the Disaster Resilience Leadership Academy. His research focuses on the intersection of climate change, mental health and resilience. Buttell’s research focuses on improving family functioning by eliminating domestic violence and improving the effectiveness of batterer intervention programs.

The two are conducting a survey and will later lead focus groups to determine the seriousness of IPV locally. Ferreira said that while IPV has been a public health issue long before the pandemic, cases of reported IPV typically rise after disasters.

“This disaster, however, is different and is a slow onset crisis,” he said. “Due to associated stressors of COVID-19, such as financial strain and substance abuse, we can expect to see a significant increase in reported cases. The biggest concern is if the needed resources to mitigate and address this issue will be available.

Ferreira and Buttell want to better understand how a pandemic differs from other types of disasters in terms of disaster preparation and response, explore changes in IPV during this time period and study whether COVID-19 pushed families into experiencing IPV for the first time.

They cite local crime statistics from April showing aggravated domestic assaults rising 37 percent on the year, while other violent crimes were down 25 percent.

Their own preliminary data appears to support that trend.  Of 275 women surveyed, 59 percent reported an escalation of IPV among those who experienced it prior to the pandemic. In addition, 88 percent felt nervous and stressed in the past month and 95 percent expressed worry about the ongoing impacts of COVID-19.

“When completed, this research will provide critical information to policymakers about the impact of COVID-19 on relational stress and coping strategies for families experiencing IPV,” the paper says.

“It might suggest that shelter-in-place strategies have differential impacts on families experiencing IPV. Indeed, such data would reinforce the anecdotal evidence that prompted the recent call of the United Nations for urgent action to combat the worldwide surge in domestic violence.”

The researchers were referring to a statement in April in which the U.N. urged all government to make the prevention of domestic violence against women a key part of national response plans for COVID-19, from declaring shelters as essential services to ensuring that judicial systems continue to prosecute abusers.

Ferreira and Buttell will hold focus groups in the coming months to explore impact of IPV on women and investigate their resilience. “The end goal is to develop a response model to mitigate the impact of future events,” Ferreira said,


SEE ORIGINAL STUDY




Filters close

Showing results

110 of 3321
Newswise: 243389_web.jpg
Released: 18-Sep-2020 10:55 AM EDT
Potential new drug to mitigate SARS-CoV-2 infection consequences
University of Malaga

Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

Newswise: 243400_web.jpg
Released: 18-Sep-2020 10:40 AM EDT
Most homemade masks are doing a great job, even when we sneeze, study finds
University of Illinois at Urbana-Champaign

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Sep-2020 8:00 AM EDT Released to reporters: 18-Sep-2020 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.

Released: 17-Sep-2020 5:50 PM EDT
AERA and OECD to Co-Host Webinar on Education Research Worldwide in a Covid and Post-Covid World
American Educational Research Association (AERA)

The American Educational Research Association (AERA) and the Organisation for Economic Co-operation and Development (OECD) will co-host a webinar on “Education Research Worldwide in a Covid and Post-Covid World” at 9:30-11:00 am EDT Wednesday, September 23.

Newswise: 243232_web.jpg
Released: 17-Sep-2020 4:20 PM EDT
Study shows first proof that a safer UV light effectively kills virus causing COVID-19
Hiroshima University

A study conducted by Hiroshima University researchers found that using Ultraviolet C light with a wavelength of 222 nanometers which is safer to use around humans effectively kills SARS-CoV-2 -- the first research in the world to prove its efficacy against the virus that causes COVID-19.

Newswise:Video Embedded american-academy-of-dermatology-honors-detroit-physician-iltefat-h-hamzavi-with-national-patient-care-hero-award
VIDEO
Released: 17-Sep-2020 4:00 PM EDT
American Academy of Dermatology honors Detroit physician Iltefat H. Hamzavi with national “Patient Care Hero” award
American Academy of Dermatology

The American Academy of Dermatology has named board-certified dermatologist Iltefat H. Hamzavi, MD, FAAD, a Patient Care Hero for his innovative use of light therapy to sanitize masks needed by frontline health care workers.

access_time Embargo lifts in 2 days
Embargo will expire: 22-Sep-2020 11:00 AM EDT Released to reporters: 17-Sep-2020 3:20 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Sep-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 17-Sep-2020 3:05 PM EDT
Does a New Study Give Evidence that the Coronavirus Was Made In a Lab?
Newswise

Scientists in a new paper make strong claims regarding evidence that the COVID-19 virus did not originate in nature—the prevailing theory—but instead was made in a lab. According to six leading experts in evolutionary biology and infectious disease consulted by Newsweek, the paper offers no new information, makes numerous unsubstantiated claims and its scientific case is weak.


Showing results

110 of 3321

close
1.09573